Gokemeijer, Jochem
Wen, Yi
Jawa, Vibha
Mitra-Kaushik, Shibani
Chung, Shan
Goggins, Alan
Kumar, Seema
Lamberth, Kasper
Liao, Karen
Lill, Jennie
Phung, Qui
Walsh, Robin
Roberts, Brian J.
Swanson, Michael
Singh, Inderpal
Tourdot, Sophie
Kroenke, Mark A.
Rup, Bonita
Goletz, Theresa J.
Gupta, Swati
Malherbe, Laurent
Pattijn, Sofie
Article History
Received: 20 March 2023
Accepted: 12 May 2023
First Online: 2 June 2023
Declarations
:
: Jochem G. and Vibha J. are employees of Bristol Myers Squibb, Yi W., Robin W., and Laurent M. are employees of Eli Lilly and Company. Shibani Mitra-Kaushik is an employee of Takeda Pharmaceuticals. Theresa Goletz is an employee of GSK. Bonita Rup works as an independent consultant. Swati Gupta is employee of AbbVie. Jennie Lill and Qui Phung are employees of Genentech. Mark Kroenke is an employee of Amgen. Seema Kumar is an employee of EMD Serono. Alan Goggins is an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. Karen Liao is an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA currently, and was employed by GSK at survey participation.
: The views and opinions expressed in this manuscript do not represent the views and opinions of their employers.